I D
× COMMENTARYCOVER STORYIN THE NEWSNEWSFRONTSCHEMENTATOR + Show More
Chemical EngineeringChementator Briefs
Ethylene dichloride Recently, Chemetry (Moss Landing, Calif.; www.chemetrycorp.com) and Braskem…
BUSINESS NEWSTECHNICAL & PRACTICALFEATURE REPORTFACTS AT YOUR FINGERTIPSTECHNOLOGY PROFILEENGINEERING PRACTICEEQUIPMENT & SERVICESFOCUSNEW PRODUCTS + Show More

Comment Business & Economics

Antibody-drug pair

By Chemical Engineering |

Lonza Group Ltd. (Basel, Switzerland; edlinks.chemengonline.com/6896-549) plans to start large-scale production of antibody drug conjugates (ADCs), an emerging class of products utilized mainly for the treatment of cancer. The plant, located in Visp, Switzerland, will have an initial production capacity of over 100 kg/yr when it comes on line next year. ADCs are made by coupling a highly active chemical substance with a biotechnologically manufactured antibody.
Related Content

Chemical Engineering publishes FREE eletters that bring our original content to our readers in an easily accessible email format about once a week.
Subscribe Now
Video - Do you really need a thermowell?
The influence of IIoT in the dewatering process step of pigment production
The Big 6 level measurement technologies, where to use them and why
Top five technologies for drying in chemical applications
Crude distillation unit (CDU) optimization

View More